(English) GRÜNENTHAL: Dennis Sabala, Product Owner Omnichannel DACH | GenAI Goes Commercial Pharma – Hype, Reality and Agile Execution

(English) GRÜNENTHAL: Dennis Sabala, Product Owner Omnichannel DACH | GenAI Goes Commercial Pharma – Hype, Reality and Agile Execution

How can generative AI be turned from hype into hands-on value in pharma? In his DigIT Pharma & eHealth 2024 presentation, Dennis Sabala (Product Owner Omnichannel DACH at Grünenthal) shares how the company is shaping transformation with a clear framework, hands-on pilot projects, and scalable AI use cases.

Discover:

– How Grünenthal translates GenAI from pilots to business-as-usual

– Which concrete use cases are already in motion – from MLR review to content personalization

– Why structured AI governance and strong change management make all the difference

Download the full presentation for free now >>>